newswise.com
Cure8 news brief
Why This Matters
The review and original research highlighted here focus on AI-driven multi-omics and single-cell approaches that aim to improve biomarker discovery, diagnosis, and personalized treatment strategies relevant to Crohn’s disease and IBD.
These technological advances may influence future diagnostics, biomarkers, and targeted therapies for people with IBD as the field translates findings into clinical tools.
Who Should Pay Attention
Researchers working on IBD genomics, microbiome, and biomarker discovery; clinicians interested in emerging diagnostic tools and precision medicine for Crohn’s disease; patients and advocates tracking research advances in IBD diagnostics and therapeutics.
Study Snapshot
Story typeResearch paper
Evidence typeClinical study
Source depthFull source text
What To Know
This SLAS Technology volume includes a review on AI/ML integration of multi-omics (genomics, proteomics, transcriptomics, metabolomics, microbiome) in Crohn’s disease and several original-research articles (including single-cell/spatial transcriptomics and biomarker/discovery tools).
The article is a journal issue summary rather than a single clinical trial report.
Keep In Mind
This item is an issue summary from SLAS Technology describing multiple research articles and a review. It summarizes research directions and methods (AI/ML, single-cell and spatial transcriptomics, nanozyme glucose sensors) rather than reporting clinical outcomes. Individual studies will require direct reading for study design, sample size, and clinical relevance.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publicationnewswise.com
Indexed viaGoogle News
Source typeWeb article
PublishedSep 30, 2026, 11:17 AM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
From signals to systems: the epigenetic-microbiome-mitochondrial axis in IBD pathogenesis.
The review highlights how microbial metabolites, epigenetic regulation, and mitochondrial metabolism interact to shape inflammation and barrier function in IBD. Understanding these links could help identify new...
AI-augmented analysis sheds new light on Crohn's disease complications
Fibrosis (irreversible bowel scarring) is a major cause of surgery in Crohn’s disease. This study points to molecular and microbiome patterns that may help predict or distinguish fibrosis from active inflammation, which...
Identification of ubiquitination-related key biomarkers and immune infiltration in Crohn's ...
This paper highlights potential ubiquitination-related genes and immune-cell patterns that could help researchers understand Crohn’s disease biology and point to new targets for lab validation. For patients, it signals...